Condition: Respiratory Distress Syndrome · Pre-term Infants · Sponsor: Aerogen Pharma Limited
This is a 2-part, prospective, randomized, blinded, sham-controlled, multi-center study comparing preterm subjects with RDS who are treated with APC-0101 and nCPAP/NIV to subjects treated with nCPAP/NIV alone (Sham). In Part 1, subjects will be followed until they reach 40 weeks post-menstrual age (PMA) or are discharged from the NICU, whichever comes first. In Part 2, subjects will undergo post-term follow-up through 24 months corrected age.
This description comes directly from the study's public registry record.
Shannon Strom · 9196026411 · sstrom@aerogenpharma.com
Always discuss trial participation with your own doctor first.
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | Recruiting |
| Jacobs Medical Center | La Jolla, California, United States | Recruiting |
| UF Health Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Advent Health | Orlando, Florida, United States | Recruiting |
| Memorial Hospital of South Bend | South Bend, Indiana, United States | Recruiting |
| Goryeb Children's Hospital | Morristown, New Jersey, United States | Recruiting |
| The Trustees of Columbia University in the City of New York | New York, New York, United States | Recruiting |
| Montefiore Medical Center | The Bronx, New York, United States | Recruiting |
| Maria Farreri Children's Hospital | Valhalla, New York, United States | Recruiting |
| Christus Children's Hospital | San Antonio, Texas, United States | Recruiting |
| University of Virginia School of Medicine | Charlottesville, Virginia, United States | Recruiting |
| WVU Medicine Children's Hospital | Morgantown, West Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06776783